Literature DB >> 28028717

Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine.

Shi-Wei Liu1, Xiao-Yang Xu2, Jie Xu3, Jiu-Yun Yuan2, Wei-Kang Wu4, Ning Zhang1, Ze-Liang Chen5.   

Abstract

OBJECTIVES: To investigate the resistance and virulence profiles of uropathogenic Escherichia coli (UPEC) and its treatment by Chinese medicine (CM) Fuzheng Qingre Lishi Formula (, FQLF).
METHODS: UPEC strains were isolated from recurrent urinary tract infections (UTIs) patients. Patient sensitivities to 17 antibiotics were tested by the disk diffusion method. Virulence genes were screened by plolymerase chain reaction. A mouse model was constructed using a multi-drug resistant and virulent UPEC strain and treated with FQLF or the antibiotic imipenem. The treatment efficacy was evaluated by bacterial clearance from urine and the urinary organs.
RESULTS: A total of 90 UPEC strains were collected, and 94.4% of the isolates were resistant to at least 1 antibiotic. Approximately 66.7% of the UPEC strains were multi-drug resistant. More than one virulence gene was found in 85.6% of the isolates. The extended-spectrum β-lactamases (ESBL)-positive strains were more resistant than the negative ones. The virulence gene number was positively correlated with the resistance number (P<0.05). A mouse model was successfully constructed using UPEC10. Treatment with either FQLF or antibiotics significantly cleared bacteria from the mouse urine after 14 days. In the untreated control, the bacteria lasted for 28 days. FQLF treatment of the UTI mouse model greatly reduced the bacterial number in the kidney and bladder, but could not completely clear the bacteria.
CONCLUSIONS: Multi-drug resistance is common among UPEC isolates, and the resistance is positively related with virulence. FQLF could treat UPEC UTIs, but could not completely clear the bacteria from the host.

Entities:  

Keywords:  Chinese medicine; multi-drug resistance; urinary tract infection; uropathogenic Escherichia coli

Mesh:

Substances:

Year:  2016        PMID: 28028717     DOI: 10.1007/s11655-016-2738-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  9 in total

Review 1.  Virulence factors of uropathogenic Escherichia coli.

Authors:  L Emody; M Kerényi; G Nagy
Journal:  Int J Antimicrob Agents       Date:  2003-10       Impact factor: 5.283

2.  Intracellular bacterial biofilm-like pods in urinary tract infections.

Authors:  Gregory G Anderson; Joseph J Palermo; Joel D Schilling; Robyn Roth; John Heuser; Scott J Hultgren
Journal:  Science       Date:  2003-07-04       Impact factor: 47.728

Review 3.  Theory of traditional Chinese medicine and therapeutic method of diseases.

Authors:  Ai-Ping Lu; Hong-Wei Jia; Cheng Xiao; Qing-Ping Lu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

4.  Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.

Authors:  Richard E Berger
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

5.  Traditional chinese medicine: an alternative treatment option for refractory recurrent urinary tract infections.

Authors:  Ning Zhang; Liuyu Huang; Shiwei Liu; Yufei Wang; Yanlan Luo; Xing Jin; Jie Guo; Yuehua Ke; Jiankui Chen; Xitong Yuan; Zeliang Chen
Journal:  Clin Infect Dis       Date:  2013-01-29       Impact factor: 9.079

Review 6.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

7.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise.

Authors:  J R Johnson; A L Stell
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

8.  A murine model of urinary tract infection.

Authors:  Chia-Suei Hung; Karen W Dodson; Scott J Hultgren
Journal:  Nat Protoc       Date:  2009-07-30       Impact factor: 13.491

9.  Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.

Authors:  Mohammad Reza Asadi Karam; Mana Oloomi; Mehdi Mahdavi; Mehri Habibi; Saeid Bouzari
Journal:  Vaccine       Date:  2013-01-07       Impact factor: 3.641

  9 in total
  3 in total

1.  Identification of potential matrix metalloproteinase-2 inhibitors from natural products through advanced machine learning-based cheminformatics approaches.

Authors:  Ruoqi Yang; Guiping Zhao; Bin Cheng; Bin Yan
Journal:  Mol Divers       Date:  2022-06-30       Impact factor: 2.943

2.  Chitin Oligosaccharide (COS) Reduces Antibiotics Dose and Prevents Antibiotics-Caused Side Effects in Adolescent Idiopathic Scoliosis (AIS) Patients with Spinal Fusion Surgery.

Authors:  Yang Qu; Jinyu Xu; Haohan Zhou; Rongpeng Dong; Mingyang Kang; Jianwu Zhao
Journal:  Mar Drugs       Date:  2017-03-14       Impact factor: 5.118

3.  Effectiveness of Chinese Herbal Medicine Combined with Antibiotics for Extensively Drug-Resistant Enterobacteria and Nonfermentative Bacteria Infection: Real-Life Experience in a Retrospective Cohort.

Authors:  Yangping Cai; Qing Zhang; Yuefeng Fu; Li Li; Ning Zhao; Aiping Lu; Qingquan Liu; Miao Jiang
Journal:  Biomed Res Int       Date:  2017-10-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.